Optimi Health Announces First PTSD Patients Treated with MDMA Capsules in Australia
Press Release Additional 700 Doses Ordered by Mind Medicine Australia as Demand Surges Vancouver, British Columbia–(Newsfile Corp. – October 23, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company”), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing in botanical psilocybin and MDMA, is proud to announce that the first […]